| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 49.728 | 108.869 | 97.964 | 57.977 | 58.890 | 58.522 | 58.297 |
| Total Income - EUR | - | - | - | 51.501 | 114.086 | 104.278 | 60.690 | 61.777 | 62.214 | 63.211 |
| Total Expenses - EUR | - | - | - | 49.916 | 111.055 | 103.851 | 63.887 | 59.876 | 63.031 | 64.160 |
| Gross Profit/Loss - EUR | - | - | - | 1.585 | 3.032 | 427 | -3.197 | 1.901 | -817 | -949 |
| Net Profit/Loss - EUR | - | - | - | 1.070 | 1.891 | -537 | -3.804 | 1.295 | -1.439 | -949 |
| Employees | - | - | - | 5 | 4 | 4 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Marsimab 2001 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 535 | 1.141 | 628 | 156 | 0 | 0 |
| Current Assets | - | - | - | 9.156 | 6.626 | 7.356 | 3.822 | 4.160 | 6.283 | 5.302 |
| Inventories | - | - | - | 8.587 | 5.801 | 6.483 | 3.481 | 3.417 | 5.372 | 3.874 |
| Receivables | - | - | - | 0 | 461 | 171 | 0 | 100 | 343 | 781 |
| Cash | - | - | - | 569 | 364 | 702 | 341 | 644 | 569 | 646 |
| Shareholders Funds | - | - | - | 1.121 | 2.991 | 2.356 | -1.501 | -210 | -1.648 | -2.587 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 8.035 | 4.187 | 6.141 | 5.955 | 4.558 | 7.963 | 7.912 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Marsimab 2001 S.r.l.